Annual report [Section 13 and 15(d), not S-K Item 405]

STOCK-BASED COMPENSATION

v3.25.1
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

Note 13. STOCK-BASED COMPENSATION

 

The Company granted options and restricted stock awards under its 2014 Equity Incentive Plan (the “2014 Plan”). Under the 2014 Plan, the Company was authorized to grant options or restricted stock for up to 2,000,000 shares of Common Stock. On June 6, 2023, the Company received stockholder approval to increase the number of authorized shares from 1,142,857 to 2,000,000. Options or restricted stock awards may be granted to employees, the Company’s board of directors, and external consultants who provide services to the Company. Options and restricted stock awards granted under the 2014 Plan have vesting schedules with terms of one to three years and become fully exercisable based on specific terms imposed at the date of grant. The 2014 Plan expired according to the respective 10-year term of the 2014 Plan in March 2024. A new 2024 Incentive Compensation Plan (the “2024 Plan”) was approved at the Annual Meeting of Shareholders on June 4, 2024.

 

The Company has recorded stock-based compensation expense related to the issuance of restricted stock awards in the following line items in the accompanying condensed consolidated statements of operations:

 

    2024     2023  
             
Research and development   $ 99,174     $ 37,131  
Selling, general and administrative     890,507       711,692  
Total stock-based compensation expense   $ 989,681     $ 748,823  

 

The following table summarizes stock option activity under the 2014 and 2024 Plans:

 

   

Number of

options

   

Weighted-

average

exercise price

   

Weighted-

average

remaining

contractual

term (in years)

   

Aggregate

intrinsic value

 
Outstanding at December 31, 2023     683,695     $ 3.99       2.9     $ 158,332  
Granted                        
Exercised     (208,031 )     1.16              
Forfeited     (171,539 )     2.16              
Outstanding at December 31, 2024     304,125     $ 6.95       4.20     $  
                                 
Vested and exercisable at December 31, 2024     304,125     $ 6.95       4.20     $  

 

As of December 31, 2024, there was no unrecognized compensation cost related to non-vested stock options.

 

During the year ended December 31, 2024, 208,031 options were exercised at an exercise price of $1.155, of which 143,183 options were from a cashless exercise, and 137,854 options were forfeited due to a cashless exercise.

 

 

Restricted Stock Awards

 

The following table summarizes restricted stock award activity under the 2014 and 2024 Plan:

 

                      As of December 31, 2024  
    Number of
restricted
stock awards
(RSA)
    Weighted-
average
grant price
    FMV on
grant date
    Vested
number
of RSA
    Unvested
number
of RSA
 
Balance at December 31, 2023     540,969     $ 2.24     $ 1,209,400       462,298       78,671  
Granted     865,423       1.81       1,570,834       517,941       347,482  
Forfeited     (77,096 )     1.80       (139,173 )           (77,096 )
Balance at December 31, 2024     1,329,296     $ 2.24     $ 2,641,061       980,239       349,057  

 

During the year ended December 31, 2024, the Company issued restricted stock awards (“RSAs”) for 865,423 shares of Common Stock to employees, non-employees, and the Board of Directors. The shares vest in equal monthly installments over terms of between immediately up to three years, subject to the employees and non-employees providing continuous service through the vesting date. During the year ended December 31, 2024, 31,973 shares vested from RSAs granted prior to January 1, 2024, and 517,943 shares vested from RSAs granted during the year ended December 31, 2024.

 

During the year ended December 31, 2023, the Company issued RSAs for 431,028 shares of Common Stock to employees and non-employees. The shares vest in equal monthly installments over terms of between immediately up to one year, subject to the employees and non-employees providing continuous service through the vesting date. During the year ended December 31, 2023, 59,051 shares vested from RSAs previously issued.